ABCELLERA BIOLOGICS INC's ticker is ABCL and the CUSIP is 00288U106. A total of 164 filers reported holding ABCELLERA BIOLOGICS INC in Q2 2022. The put-call ratio across all filers is 0.40 and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $17,358,238 | -28.8% | 3,773,530 | 0.0% | 89.37% | -2.2% |
| Q2 2023 | $24,377,004 | -14.3% | 3,773,530 | 0.0% | 91.35% | +0.2% |
| Q1 2023 | $28,452,416 | -25.6% | 3,773,530 | 0.0% | 91.13% | -3.5% |
| Q4 2022 | $38,225,859 | +2.4% | 3,773,530 | 0.0% | 94.47% | +2.0% |
| Q3 2022 | $37,320,000 | -7.1% | 3,773,530 | 0.0% | 92.58% | -0.5% |
| Q2 2022 | $40,188,000 | +9.2% | 3,773,530 | 0.0% | 93.02% | +2.1% |
| Q1 2022 | $36,791,000 | -31.8% | 3,773,530 | 0.0% | 91.10% | +1.5% |
| Q4 2021 | $53,961,000 | -28.6% | 3,773,530 | 0.0% | 89.75% | +4.2% |
| Q3 2021 | $75,584,000 | -9.0% | 3,773,530 | 0.0% | 86.10% | +8.2% |
| Q2 2021 | $83,018,000 | -35.2% | 3,773,530 | 0.0% | 79.60% | -7.6% |
| Q1 2021 | $128,149,000 | -15.6% | 3,773,530 | 0.0% | 86.19% | +1.3% |
| Q4 2020 | $151,847,000 | – | 3,773,530 | – | 85.11% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Founders Fund VII Management, LLC | 3,773,530 | $75,584,000 | 86.10% |
| Gruss & Co., LLC | 430,407 | $8,625,000 | 24.12% |
| SB Management Ltd | 9,817,190 | $196,736,000 | 20.16% |
| GUARDIAN CAPITAL ADVISORS LP | 3,836,414 | $76,767,000 | 7.97% |
| Intellectus Partners, LLC | 1,223,429 | $24,518,000 | 5.93% |
| HARVARD MANAGEMENT CO INC | 4,105,095 | $82,266,000 | 4.82% |
| ArchPoint Investors | 461,289 | $9,244,000 | 2.77% |
| Belmont Capital, LLC | 150,000 | $3,006,000 | 2.44% |
| CLOUGH CAPITAL PARTNERS L P | 971,297 | $19,465,000 | 1.18% |
| Orbimed Advisors | 4,180,768 | $83,783,000 | 0.92% |